An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.; Division of Nephrology, Department of Medicine, University of California Davis, Davis, California, USA.; Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Division of Nephrology, Department of Medicine, Yale School of Medicine and Yale New Haven Health System, New Haven, Connecticut, USA.; Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
Authors
Lo Joan C, Beck Gerald J, Kaysen George A, Chan Christopher T, Kliger Alan S, Rocco Michael V, Chertow Glenn M
Studies
Abstract
End-stage renal disease is associated with elevations in circulating prolactin concentrations, but the association of prolactin concentrations with intermediate health outcomes and the effects of hemodialysis frequency on changes in serum prolactin have not been examined.